The approval of the first central counterparty (CCP) under the European Market Infrastructure Regulation (EMIR) – Sweden’s Nasdaq OMX on March 18 – has focused attention on how a clearing determination will be applied across the European Union (EU). Alongside an assortment of interest rate derivatives, Nasdaq OMX was authorised to clear several single-name, basket and equity index futures and options, kick-starting a six-month process by the European Securities and Markets Authority (ESMA) to determine whether a clearing obligation should apply for those classes of derivatives.
Given this process is now under way, ISDA and its members believe the criteria used to determine a clearing obligation, as proposed in an ESMA discussion paper published on July 12, 2013, must be carefully considered. In particular, the criteria used to define a ‘class’ of equity derivatives for the purposes of determining a clearing mandate should be highly granular, taking into account both the specificities of the equity derivatives market, as well as the important differences between exchange-traded and over-the-counter (OTC) instruments. An overly broad definition for an equity derivatives class could mean certain products unsuitable for clearing end up being captured by a clearing mandate, which would ultimately be detrimental for market participants that rely on those instruments for investment and risk management purposes.
There is already a well-developed cleared business for exchange-traded contracts, which make up the vast majority of the overall equity derivatives market, and this has proved to be highly responsive to client demand. Where there has been a need for greater standardisation, exchange-traded, cleared contracts have emerged – and this trend is expected to continue in the future. A number of OTC products are becoming increasingly standardised, and may migrate to exchange trading and clearing over time as customer need for these services grows.
Despite the size of the cleared exchange-traded market, however, there continues to be strong demand for the flexibility and customisation offered by non-cleared OTC products. These instruments exist because they allow market participants to meet unique, tailored hedging and investment needs – demands that cannot be met by using more standardised contracts. An overly broad clearing mandate could leave end-users unable to access customised instruments that meet their specific objectives, resulting either in an increase in risk in the system or a restriction in investment choices by market participants.
As recognised in EMIR, and by ESMA in its joint draft regulatory technical standards on risk mitigation techniques for non-cleared derivatives2, there is a role for tailored OTC contracts that meet end-user risk management needs, but which aren’t suitable for clearing. Those customised, non-cleared trades are subject to mandatory reporting, and capital and margin requirements will be applied to mitigate other potential risks.
Documents (4) for Central Clearing in the Equity Derivatives Market
Latest
Episode 51: Trading Places
Markets have been volatile so far this year, but what has this meant for market liquidity? The Swap talks to Chris Edmonds from Intercontinental Exchange on trading activity and the market, economic and geopolitical outlook. Please view this page via...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
ISDA, SIFMA and FIA Comment on Enhanced Supplementary Leverage Ratio Reforms
ISDA, the Securities Industry and Financial Markets Association (SIFMA) and FIA have submitted a joint comment letter to the Federal Reserve, Federal Deposit Insurance Corporation and Office of the Comptroller of the Currency strongly supporting the proposed recalibration of the...